India Makers Shift Focus From Expiring U.S Patents To Niche Markets
This article was originally published in PharmAsia News
Executive Summary
The approaching end of the U.S. patent cliff is leading some major India drug makers to shift their focus to marketing contraceptives as a new growth area.